The prefilled glucagon pen is specifically designed for the rapid and easy treatment of a hypoglycaemic episode.
The first pre-filled pen specifically designed for treating severe hypoglycaemia has been released in the UK.
Ogluo is a first-of-a-kind prefilled glucagon pen specifically designed for the rapid and easy treatment of a hypoglycaemic episode.
Current glucagon treatments on the market require a number of steps to mix the glucagon powder and liquid prior to administration.
Severe hypoglycaemia is a common side effect of insulin use with 30-40% of people with Type 1 diabetes experiencing at least one severe episode per year.
It is defined as a an event requiring the assistance of another person to actively administer carbohydrates, glucagon, or take other corrective actions.
The new device is available in two dosing options, one for adults and another for children.
Peace of mind.
Dr Patrick English, Consultant in Diabetes, Endocrinology, General and Acute Medicine, said the new device could provide some peace of mind to diabetics.
He said; “Many people with type 1 diabetes live in fear of severe hypoglycaemic episodes. These episodes can be frightening for the person with diabetes, as well as for family, friends and carers who don’t always know what to do or how to help.
“Currently, the administration of glucagon to treat such an episode, when someone is unconscious or unable to take glucose orally, requires a number of steps to mix the glucagon powder and liquid prior to administration. This is often not done successfully under pressure, which may delay recovery.
“Providing glucagon as a liquid in a new, easy-to-use auto injection device could make this process far simpler and mean greater freedom and security for people living with diabetes and their families, friends and carers”
